Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018

On the basis of the type of technology, the market is segmented into cell-based, bead-based and others. The cell-based flow cytometry segment accounted for the largest share of the global market in 2013. This is mainly because cell-based assays encompass the benefits of testing the compounds activity against molecular targets within the context of living cells; thus it is increasingly used in drug discovery processes. However, bead based flow cytometry is expected to growth at a higher rate as compared to the cell based ones. Furthermore, on the basis of products, the global market has been segmented into instruments, reagents and consumables, software, services, and accessories.

On the basis of the type of applications, the global flow cytometry market is classified into three categories, namely, research fields, clinical applications, and industrial applications. Research fields commands the major chunk of the global market in 2013; while, the clinical application is the fastest growing segment in this market. On the basis of the end users, the global market has been segmented into commercial organizations, hospitals, academic institutes, medical schools, and clinical testing labs.

Increasing applications of technological advancements in flow cytometry instruments, fostering research activities in the field of life sciences, growing clinical trials, fostering prevalence of HIV and cancer, launch of new reagents for specific applications such as diagnostics, drug discovery, and the development of user friendly and intuitive software's are driving the growth of the market. However, a number of factors include high cost of instruments, reluctance among researchers to use flow cytometers (due to complexity and consumption of large space), dearth of training, and lack of awareness among probable users are restricting the market growth.

North America and a major part of the European region are saturated markets for flow cytometry products. The emerging markets including China and India are becoming attractive for the companies engaged in the development and marketing of the products. Various economic developments and growing prevalence of HIV/AIDS, growing number of research initiatives, increasing government support, and growing focus of both international and domestic players are the key factors propelling the demand for products in the Asia-Pacific region.

As of 2013, Becton, Dikinson and Company (U.S.) holds the leadership position in flow cytometry market globally. Over the past three years, the company adopted new product launches, collaborations, and strategic acquisitions as its key business strategies to ensure its dominant position in this market. Some of the key players in this market are Becton, Dickinson and Company, Beckman Coulter, Inc. (U.S.), e Biosciences, Inc. (U.S.), EMD Millipore Corporation (U.S.), Life Technologies Corporation (U.S.), Luminex Corporation (U.S.), Miltenyi Biotec (Germany), and Partec GmbH (Germany), are some of the other key players in this market.

Scope of the report

This research report categorizes the global market into the following segments and sub-segments:

By Technology

Cell-based Flow Cytometry
Bead-based Flow Cytometry
Others
By Products

Instruments
Reagents and Consumables
Software
Services
Accessories
By Applications

Research Fields
Pharmaceutical Applications
Drug Discovery
Stem Cells Research
In Vitro Toxicity Testing
Apoptosis
Cell Cycle Analysis
Cell Sorting
Cell Viability
Immunology
Others
Clinical Applications
Organ Transplantation
Cancer
Immunodeficiency Diseases
Hematology
Others
Industrial Applications
By End Users

Commercial Organizations
Hospitals
Academic Institutes
Medical Schools
Clinical Testing Labs